Clinical Impact of the Administration of FOLFIRINOX Beyond Six Months in Advanced Pancreatic Adenocarcinoma: A Cohort Study.

导出 LinkOut

翻译打印收藏纠错

作者： Cornelia,Nitipir ^[1] ; Radu,Vrabie ^[2] ; Andreea Ioana,Parosanu ^[1] ; Raluca,Tulin ^[2] ; Bogdan,Cretu ^[1] ; Adrian,Cursaru ^[2] ; Iulian,Slavu ^[3] ; Adrian,Miron ^[4] ; Valentin,Calu ^[5] ; Maria Cristina,Orlov Slavu ^[4]

作者单位： Oncology, Elias Emergency University Hospital, Bucharest, ROU. ^[1] Oncology, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU. ^[2] Endocrinology, Emergency Hospital Prof. Dr. Agrippa Ionescu, Bucharest, ROU. ^[3] Orthopedics and Traumatology, University Emergency Hospital Bucharest, Bucharest, ROU. ^[4] Orthopedics, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU. ^[5] Surgery, Emergency Hospital Prof. Dr. Agrippa Ionescu, Bucharest, ROU. ^[6] Surgery, Elias Emergency University Hospital, Bucharest, ROU. ^[7]

关键词 chemotherapy dose-intensity maintenance pancreatic adenocarcinoma survival

DOI 10.7759/cureus.19361

PMID 34925974

发布时间 2021-12-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cureus

2021年13卷11期

e19361页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical Impact of the Administration of FOLFIRINOX Beyond Six Months in Advanced Pancreatic Adenocarcinoma: A Cohort Study.

Cureus

相似文献

Cureus

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical Impact of the Administration of FOLFIRINOX Beyond Six Months in Advanced Pancreatic Adenocarcinoma: A Cohort Study.

Cureus

相似文献

Cureus

相关期刊

检索历史清除